TickerFacts.

Medicus Pharma Ltd. (MDCX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$8.71M
As of 2025-12-31
$15.17M
As of 2026-06-30
2023-12-31: $1.72M2024-12-31: $4.16M2025-12-31: $8.71M$8.71M
2023-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$8.71M+109.0%2026-03-25, Balance as of period end
2024-12-31$4.16M+142.2%2026-03-25, Balance as of period end
2023-12-31$1.72Mn/a2025-03-28, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Medicus Pharma Ltd. (MDCX)2025-12-31$8.71M+109.0%
Oragenics Inc (OGEN)2025-12-31$4.40M+408.7%
Korsana Biosciences, Inc. (KRSA)2025-12-31$3.24M+0.2%
Genprex, Inc. (GNPX)2025-12-31$7.83M+388.9%
Lunai Bioworks Inc. (LNAI)2026-06-30$1.71Mn/m
Nanoviricides, Inc. (NNVC)2026-06-30$2.79M+79.3%
Longeveron Inc. (LGVN)2025-12-31$4.66M-75.8%
Cocrystal Pharma, Inc. (COCP)2025-12-31$7.03M-28.8%
MAIA Biotechnology, Inc. (MAIA)2025-12-31$0n/a

Compare MDCX, OGEN, KRSA, GNPX side by side · Screen every company in Pharmaceutical Preparations ↗